Screening Senyawa Pandu Inhibitor Endositosis dengan Metode Molecular Modelling
Main Article Content
Abstract
The purpose of this research is to search for compound inhibitor endocytosis by using Molecular Modeling program. Screening is performed on approximately 800,000 compounds derived from several commercial companies. From the results of virtual screening obtained 320 hits, and of this number only 175 compounds that can be obtained to test its biological activity. Biological tests showed that there were 7 compounds with moderate endocytosis inhibition capability (IC50 = 50-170 μM) to good inhibition (IC50 <50 μM). The compounds are: compound 1 (IC50 = 42 ± 4 μM), compound 2 (IC50 = 83 ± 8 μM), compound 3 (IC50 = 135 ± 58 μM), compound 4 (IC50 = 151 ± 18 μM) compound 5 (IC50 = 144 ± 18 μM), compound 6 (IC50 = 13 ± 4 μM), and compound 7 (IC50 ~ 170 μM).
Downloads
Article Details
Copyright and Licensing
For all articles published in Fullerene Journal of Chemistry, Authors retain some copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit.
Authors are free to:
- Share— copy and redistribute the material in any medium or format
- Adapt— remix, transform, and build upon the material for any purpose, even commercially.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices: You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation. No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.